PAPOFF, GIULIANA
PAPOFF, GIULIANA
Istituto di Biochimica e Biologia Cellulare - IBBC - Sede Secondaria Monterotondo
Co-Expression Network Analysis Unveiled lncRNA-mRNA Links Correlated to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance and/or Intermediate Epithelial-to-Mesenchymal Transition Phenotypes in a Human Non-Small Cell Lung Cancer Cellular Model System
2024 Fustaino, V.; Papoff, G.; Ruberti, F.; Ruberti, G.
Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages
2024 Gimmelli, Roberto; Papoff, Giuliana; Saccoccia, Fulvio; Lalli, Cristiana; Gemma, Sandra; Campiani, Giuseppe; Ruberti, Giovina
The activity of a PI3K ?-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway.
2023 Papoff, Giuliana; Presutti, Dario; Fustaino, Valentina; Parente, Andrea; Calandriello, Clelia; Alemà, Stefano; Scavizzi, Ferdinando; Raspa, Marcello; Merlino, Giuseppe; Salerno, Massimiliano; Bigioni, Mario; Binaschi, Monica; Ruberti, Giovina
Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors
2022 Saccoccia, F; Pozzetti, L; Gimmelli, R; Butini, S; Guidi, A; Papoff, G; Giannaccari, M; Brogi, S; Scognamiglio, V; Gemma, S; Ruberti, G; Campiani, G
In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines
2022 Baldini, Enke; Presutti, Dario; Favoriti, Pasqualino; Santini, Simonetta; Papoff, Giuliana; Tuccilli, Chiara; Carletti, Raffaella; Di Gioia, Cira; Lori, Eleonora; Catalina Ferent, Iulia; Gagliardi, Federica; Catania, Antonio; Pironi, Daniele; Tripodi, Domenico; D'Andrea, Vito; Sorrenti, Salvatore; Ruberti, Giovina; Ulisse, Salvatore
Tumor Growth in the High Frequency Medulloblastoma Mouse Model Ptch1+/-/Tis21KO Has a Specific Activation Signature of the PI3K/AKT/mTOR Pathway and Is Counteracted by the PI3K Inhibitor MEN1611
2021 Ceccarelli, Manuela; D'Andrea, Giorgio; Micheli, Laura; Gentile, Giulia; Cavallaro, Sebastiano; Merlino, Giuseppe; Papoff, Giuliana; Tirone, Felice
Screening and phenotypical characterization of Schistosoma mansoni histone deacetylase 8 (SmHDAC8) inhibitors as multi-stage antischistosomal agents
2019 Saccoccia, F; Brindisi, M; Gimmelli, R; Relitti, N; Guidi, A; Saraswati, Ap; Cavella, C; Brogi, S; Chemi, G; Butini, S; Papoff, G; Senger, J; Herp, D; Jung, M; Campiani, G; Gemma, S; Ruberti, G
Thiazinoquinones as New Promising Multistage Schistosomicidal Compounds Impacting Schistosoma mansoni and Egg Viability.
2019 Gimmelli R; Persico M; Imperatore C; Saccoccia F; Guidi A; Casertano M; Luciano P; Pietrantoni A; Bertuccini L; Paladino A; Papoff G; Menna M; Fattorusso C; Ruberti G.
CASP4 gene silencing in epithelial cancer cells leads to impairment of cell migration, cell-matrix adhesion and tissue invasion.
2018 Papoff, Giuliana; Presutti, Dario; Lalli, Cristiana; Bolasco, Giulia; Santini, Simonetta; Manelfi, Candida; Fustaino, Valentina; Alemà, Stefano; Ruberti, Giovina
Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production
2018 Guidi, A; Saccoccia, F; Gennari, N; Gimmelli, R; Nizi, E; Lalli, C; Paonessa, G; Papoff, G; Bresciani, A; Ruberti, G
Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model
2018 Presutti, Dario; Ceccarelli, Manuela; Micheli, Laura; Papoff, Giuliana; Santini, Simonetta; Samperna, Simone; Lalli, Cristiana; Zentilin, Lorena; Ruberti, Giovina; Tirone, Felice
Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines
2017 Fustaino, Valentina; Presutti, Dario; Colombo, Teresa; Cardinali, Beatrice; Papoff, Giuliana; Brandi, Rossella; Bertolazzi, Paola; Felici, Giovanni; Ruberti, Giovina
MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells.
2015 Presutti D; Santini S; Cardinali B; Papoff G; Lalli C; Samperna S; Fustaino V; Giannini G; Ruberti G.
N-Terminal and C-Terminal Domains of Calmodulin Mediate FADD and TRADD Interaction.
2015 Papoff G; Trivieri N; Marsilio S; Crielesi R; Lalli C; Castellani L; Balog EM; Ruberti G.
FADD-calmodulin interaction: A novel player in cell cycle regulation.
2010 Papoff G; Trivieri N; Crielesi R; Ruberti F; Marsilio S; Ruberti G.
RESISTANCE TO GEMCITABINE IN A LYMPHOMA CELL LINE RESISTANT TO FAS-MEDIATED APOPTOSIS
2004 Meli M; Tolomeo M; D'Alessandro N; Grimaudo S; Notarbartolo M; Papoff G; Ruberti G; Rausa L; Dusonchet L.
Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor
1999 Papoff, G; Hausler, P; Eramo, A; Pagano, Mg; Di Leve, G; Signore, A; Ruberti, G
Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B.
1998 Häusler P; Papoff G; Eramo A; Reif K; Cantrell DA; Ruberti G
The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
1998 Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L.
Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway.
1998 Prasad NK; Papoff G; Zeuner A; Bonnin E; Kazatchkine MD; Ruberti G; Kaveri SV
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Co-Expression Network Analysis Unveiled lncRNA-mRNA Links Correlated to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance and/or Intermediate Epithelial-to-Mesenchymal Transition Phenotypes in a Human Non-Small Cell Lung Cancer Cellular Model System | 1-gen-2024 | Fustaino, V.; Papoff, G.; Ruberti, F.; Ruberti, G. | |
| Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages | 1-gen-2024 | Gimmelli, Roberto; Papoff, Giuliana; Saccoccia, Fulvio; Lalli, Cristiana; Gemma, Sandra; Campiani, Giuseppe; Ruberti, Giovina | |
| The activity of a PI3K ?-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway. | 1-gen-2023 | Papoff, Giuliana; Presutti, Dario; Fustaino, Valentina; Parente, Andrea; Calandriello, Clelia; Alemà, Stefano; Scavizzi, Ferdinando; Raspa, Marcello; Merlino, Giuseppe; Salerno, Massimiliano; Bigioni, Mario; Binaschi, Monica; Ruberti, Giovina | |
| Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors | 1-gen-2022 | Saccoccia, F; Pozzetti, L; Gimmelli, R; Butini, S; Guidi, A; Papoff, G; Giannaccari, M; Brogi, S; Scognamiglio, V; Gemma, S; Ruberti, G; Campiani, G | |
| In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines | 1-gen-2022 | Baldini, Enke; Presutti, Dario; Favoriti, Pasqualino; Santini, Simonetta; Papoff, Giuliana; Tuccilli, Chiara; Carletti, Raffaella; Di Gioia, Cira; Lori, Eleonora; Catalina Ferent, Iulia; Gagliardi, Federica; Catania, Antonio; Pironi, Daniele; Tripodi, Domenico; D'Andrea, Vito; Sorrenti, Salvatore; Ruberti, Giovina; Ulisse, Salvatore | |
| Tumor Growth in the High Frequency Medulloblastoma Mouse Model Ptch1+/-/Tis21KO Has a Specific Activation Signature of the PI3K/AKT/mTOR Pathway and Is Counteracted by the PI3K Inhibitor MEN1611 | 1-gen-2021 | Ceccarelli, Manuela; D'Andrea, Giorgio; Micheli, Laura; Gentile, Giulia; Cavallaro, Sebastiano; Merlino, Giuseppe; Papoff, Giuliana; Tirone, Felice | |
| Screening and phenotypical characterization of Schistosoma mansoni histone deacetylase 8 (SmHDAC8) inhibitors as multi-stage antischistosomal agents | 1-gen-2019 | Saccoccia, F; Brindisi, M; Gimmelli, R; Relitti, N; Guidi, A; Saraswati, Ap; Cavella, C; Brogi, S; Chemi, G; Butini, S; Papoff, G; Senger, J; Herp, D; Jung, M; Campiani, G; Gemma, S; Ruberti, G | |
| Thiazinoquinones as New Promising Multistage Schistosomicidal Compounds Impacting Schistosoma mansoni and Egg Viability. | 1-gen-2019 | Gimmelli R; Persico M; Imperatore C; Saccoccia F; Guidi A; Casertano M; Luciano P; Pietrantoni A; Bertuccini L; Paladino A; Papoff G; Menna M; Fattorusso C; Ruberti G. | |
| CASP4 gene silencing in epithelial cancer cells leads to impairment of cell migration, cell-matrix adhesion and tissue invasion. | 1-gen-2018 | Papoff, Giuliana; Presutti, Dario; Lalli, Cristiana; Bolasco, Giulia; Santini, Simonetta; Manelfi, Candida; Fustaino, Valentina; Alemà, Stefano; Ruberti, Giovina | |
| Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production | 1-gen-2018 | Guidi, A; Saccoccia, F; Gennari, N; Gimmelli, R; Nizi, E; Lalli, C; Paonessa, G; Papoff, G; Bresciani, A; Ruberti, G | |
| Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model | 1-gen-2018 | Presutti, Dario; Ceccarelli, Manuela; Micheli, Laura; Papoff, Giuliana; Santini, Simonetta; Samperna, Simone; Lalli, Cristiana; Zentilin, Lorena; Ruberti, Giovina; Tirone, Felice | |
| Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines | 1-gen-2017 | Fustaino, Valentina; Presutti, Dario; Colombo, Teresa; Cardinali, Beatrice; Papoff, Giuliana; Brandi, Rossella; Bertolazzi, Paola; Felici, Giovanni; Ruberti, Giovina | |
| MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells. | 1-gen-2015 | Presutti D; Santini S; Cardinali B; Papoff G; Lalli C; Samperna S; Fustaino V; Giannini G; Ruberti G. | |
| N-Terminal and C-Terminal Domains of Calmodulin Mediate FADD and TRADD Interaction. | 1-gen-2015 | Papoff G; Trivieri N; Marsilio S; Crielesi R; Lalli C; Castellani L; Balog EM; Ruberti G. | |
| FADD-calmodulin interaction: A novel player in cell cycle regulation. | 1-gen-2010 | Papoff G; Trivieri N; Crielesi R; Ruberti F; Marsilio S; Ruberti G. | |
| RESISTANCE TO GEMCITABINE IN A LYMPHOMA CELL LINE RESISTANT TO FAS-MEDIATED APOPTOSIS | 1-gen-2004 | Meli M; Tolomeo M; D'Alessandro N; Grimaudo S; Notarbartolo M; Papoff G; Ruberti G; Rausa L; Dusonchet L. | |
| Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor | 1-gen-1999 | Papoff, G; Hausler, P; Eramo, A; Pagano, Mg; Di Leve, G; Signore, A; Ruberti, G | |
| Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. | 1-gen-1998 | Häusler P; Papoff G; Eramo A; Reif K; Cantrell DA; Ruberti G | |
| The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis | 1-gen-1998 | Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L. | |
| Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. | 1-gen-1998 | Prasad NK; Papoff G; Zeuner A; Bonnin E; Kazatchkine MD; Ruberti G; Kaveri SV |